IRIS
FERRARINI, MANLIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.333
AS - Asia 1.172
NA - Nord America 462
SA - Sud America 124
AF - Africa 24
Totale 15.115
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.121
SG - Singapore 555
US - Stati Uniti d'America 435
CN - Cina 295
VN - Vietnam 207
FR - Francia 112
BR - Brasile 82
HK - Hong Kong 34
FI - Finlandia 29
DE - Germania 21
AR - Argentina 19
JP - Giappone 16
CH - Svizzera 15
MX - Messico 15
IQ - Iraq 9
GB - Regno Unito 8
ZA - Sudafrica 8
PK - Pakistan 7
BD - Bangladesh 6
CL - Cile 6
PH - Filippine 6
CA - Canada 5
EG - Egitto 5
ID - Indonesia 5
IN - India 5
EC - Ecuador 4
NL - Olanda 4
UA - Ucraina 4
CO - Colombia 3
IE - Irlanda 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
NI - Nicaragua 3
SA - Arabia Saudita 3
TH - Thailandia 3
UY - Uruguay 3
VE - Venezuela 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
ES - Italia 2
JM - Giamaica 2
MA - Marocco 2
MY - Malesia 2
OM - Oman 2
PY - Paraguay 2
RU - Federazione Russa 2
TN - Tunisia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BE - Belgio 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
KR - Corea 1
LT - Lituania 1
MT - Malta 1
NP - Nepal 1
PA - Panama 1
PL - Polonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 15.115
Salva come PNG Salva come JPEG
Città #
Genova 8.373
Genoa 2.809
Rapallo 1.141
Vado Ligure 748
Singapore 246
San Jose 232
Lauterbourg 107
Ho Chi Minh City 61
Ashburn 45
Hanoi 45
Beijing 32
Hong Kong 31
Helsinki 29
New York 27
Santa Clara 18
Bordighera 17
Frankfurt am Main 17
Council Bluffs 15
Tokyo 15
Zurich 14
Da Nang 10
Mexico City 10
St Louis 10
Los Angeles 9
Biên Hòa 7
Haiphong 7
Phủ Lý 7
Cairo 5
Baghdad 4
City of London 4
Guangzhou 4
Johannesburg 4
Orem 4
São Paulo 4
Amman 3
Brasília 3
Dallas 3
Des Moines 3
Managua 3
Milan 3
Nairobi 3
Nha Trang 3
Nuremberg 3
Shanghai 3
Amsterdam 2
Belford Roxo 2
Bologna 2
Cardiff 2
Cedral 2
Changsha 2
Cochabamba 2
Dalian 2
Dhaka 2
Dublin 2
Durban 2
Formosa 2
Fortaleza 2
Hangzhou 2
Karachi 2
Long Xuyen 2
Madrid 2
Montevideo 2
Nanchang 2
Naples 2
Quito 2
Quảng Ngãi 2
Recife 2
Rio de Janeiro 2
Rome 2
San Bernardo 2
San Miguel de Tucumán 2
Sanremo 2
Thái Nguyên 2
Tianjin 2
Alta Floresta 1
Alto Paraíso de Goiás 1
Amélie-les-Bains-Palalda 1
Anchorage 1
Apache Junction 1
Aparecida de Goiânia 1
Aryanah 1
Avaré 1
Baguio City 1
Bahawalpur 1
Bahía Blanca 1
Baku 1
Bandar Seri Begawan 1
Bang Phli 1
Banja Luka 1
Barcelona 1
Bari 1
Beirut 1
Belo Horizonte 1
Belém 1
Bento Gonçalves 1
Boardman 1
Bogotá 1
Boston 1
Brampton 1
Brotas de Macaúbas 1
Totale 14.227
Salva come PNG Salva come JPEG
Nome #
B CELL CHRONIC LYMPHOCYTIC LEUKEMIA: Lessons Learned from Studies of the B Cell Antigen Receptor. 214
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 214
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. 198
Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. 198
More on the determination of Ki-67 as a novel potential prognostic marker in B-cell chronic lymphocytic leukemia. 189
Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation 181
APOPTOSIS OR PLASMA CELL DIFFERENTIATION OF CD38-POSITIVE B-CHRONIC LYMPHOCYTIC LEUKEMIA CELLS INDUCED BY CROSS-LINKING OF SURFACE IGM OR IGD 176
Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen: implications for lymphomagenesis in acquired immunodeficiency syndrome. 175
Igs expressed by chronic lymphocytic leukemia B cells show limited binding-site structure variability. 175
A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI) 174
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence 170
B lymphocytes in humans express ZAP-70 when activated in vivo. 168
Accumulation of clonally-related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients 167
BAFF serum level predicts time to first treatment in early chronic lymphocytic leukemia. 167
A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients. 161
B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP-70 determination on bone marrow biopsies 160
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. 159
Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia. 159
Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia. 156
The CD38 ectoenzyme family: advances in basic science and clinical practice 152
Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements 151
Analysis of the stepwise genetic changes that occurred in an AIDS-related Burkitt\'s lymphoma. 151
Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells. 150
Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma. 149
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling 149
The human marginal zone B cell 148
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 146
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia 145
An Increased Number of Individuals with Clinically Recognized Monoclonal B-Cell Lymphocytosis Characterizes a Recent Database of Chronic Lymphocytic Leukemia Rai Stage 0. 144
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. 144
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 143
Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer. 142
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells 142
Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. 141
Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy 141
Apoptosis of Burkitt\'s lymphoma cells induced by specific interaction of surface IgM with a self-antigen. Implications for lymphomagenesis in AIDS. 141
A phase II trial with Cisplatin-Paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer. 140
Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T cell cross-priming, depending on their capacity to activate dendritic cells. 139
PNAEμ can significantly reduce Burkitt’s Lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease 139
Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. 138
Chromosome aberrations evaluated by comparative genomic hybridization in B cell chronic lymphocytic leukemia: correlation with CD38 expression 138
Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas 137
CD38 and chronic lymphocytic leukemia: a decade later. 136
Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemia. 135
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia. 135
SUBEPITHELIAL B CELLS IN THE HUMAN PALATINE TONSIL. II. FUNCTIONAL CHARACTERIZATION 135
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia. 135
CASE 1. Complete remission to corticosteroids in an octreotide-refractory thymoma 134
CD 10 is a marker for cycling cells with propensity to apoptosis in childhood ALL 134
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukaemia. 133
Immunoglobulin Gene Mutation Patterns and Heterogeneity of Marginal Zone Lymphoma 132
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia 132
Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B-cells 132
Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. 131
Chronic lymphocytic leukaemia 131
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia. 131
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia. 131
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification. 129
Evolving view of the in-vivo kinetics of chronic lymphocytic leukemia B cells. 129
Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo. 127
Recent views on B cell chronic lymphocytic leukemia pathophysiology 127
Impaired Humoral Response to Influenza Vaccine and Prolonged B Memory Cell Depletion as a Consequence of Rituximab-based Immunochemotherapy in non-Hodgkin Lymphoma Patients 127
Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient. 126
Therapeutically promising PNA complementary to a regulatory sequence for c-myc: pharmacokinetics in an animal model of human Burkitt's lymphoma 126
Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemia. 125
Identification of three subgroups of B-CELL chronic lymphocytic leukemia based upon mutations of BCL-6 and Ig V genes 124
Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. 124
Maintenance of B lymphocyte-related clones in the cerebrospinal fluid of multiple sclerosis patients. 124
IMMUNOGLOBULIN V GENE MUTAITON STATUS AND CD38 EXPRESSION AS NOVEL PROGNOSTIC INDICATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA 123
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients 123
Role of surface IgM and IgD on survival of the cells from B-cell chronic lymphocytic leukemia. 122
Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study. 122
Clinical and laboratory parameters that define clinically relevant B-CLL subgroups. 121
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach 118
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. 117
The propensity to apoptosis of centrocytes and centroblasts correlates with elevated levels of intracellular myc protein. 116
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia. 116
Immunoglobulin V genes and CD38 expression analysis in B cell chronic lymphocytic leukemia. Blood. Letter 114
The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways 113
Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion. 113
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases 110
TRANSFECTION OF THE C-MYC ONCOGENE INTO NORMAL EBV-HARBORING B CELLS RESULTS IN NEW PHENOTYPIC AND FUNCTIONAL FEATURES RESEMBLING THOSE OF BURKITT LYMPHOMA CELLS AND NORMAL CENTROBLASTS 109
CD5(+) B cells with the features of subepithelial B cells found in human tonsils 109
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates pro-apoptotic signals in chronic lymphocytic leukemia B cells 109
Serum-associated inhibition of neutrophil Fc receptors in cancer patients. 109
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia 109
Frequent mutation of the 5’ noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphomas 107
Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc 107
Chronic lymphocytic leukemia 106
Heterogeneous expression and function ofIL-21R and susceptibility to IL-21-mediated apoptosis in follicular lymphoma cells. 105
Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. Haematologica 104
Clinical categories identified by a new prognostic index reflect biological characteristics of patients in earlychronic lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL)experience. 104
Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma 104
CD38 EXPRESSION DISTINGUISHES TWO GROUPS OF B CELL-CHRONIC LYMPHOCYTIC LEUKEMIAS WITH DIFFERENT RESPONSE TO ANTI IgM ANTIBODIES AND PROPENSITY TO APOPTOSIS 103
The patterns of IL2, IFN-gamma, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar. 103
A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation 100
Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia 100
Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study. 100
The peptide nucleic acid targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma lacks immunogenicity: follow-up characterization of PNAEmu-NLS 98
Antitumor effects of PRIMA-1 and PRIMA-1met (APR246) in hematological malignancies: Still a mutant p53-dependent affair? 97
Totale 13.567
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.530
article - articoli 43.773
book - libri 0
conference - conferenze 374
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 383
Totale 89.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021192 0 0 0 0 0 0 0 0 0 89 47 56
2021/20221.239 46 75 91 141 42 69 80 305 53 132 34 171
2022/20231.375 140 91 11 173 228 271 6 124 249 6 65 11
2023/2024663 24 97 13 62 72 135 36 38 28 19 49 90
2024/20251.898 51 157 51 129 227 196 165 269 60 93 229 271
2025/20262.844 368 79 151 290 408 349 555 158 203 283 0 0
Totale 15.217